Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| 154,112 Orion Corporation A shares converted into B shares | ||||||
| By: GlobenewsWire - 25 Jan 2023 | Back to overview list |
|||||
ORION CORPORATION 154,112 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 154,112 A shares have been converted into 154,112 B shares. The conversion has been entered into the Trade Register on 25 January 2023. The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, consists of 34,032,382 A shares and 107,101,896 B shares. The number of votes of the company's shares is after the conversion 787,749,536. Orion Corporation
Publisher: Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are oncology and pain. Orion's net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki. 
|
||||||
|
||||||
 | Back to overview list | |||||